Merck (MRK -0.3%) forecasts adjusted EPS of $0.76-$0.78 in Q1, below estimates of $0.86. The...

|About: Merck & Co Inc. (MRK)|By:, SA News Editor

Merck (MRK -0.3%) forecasts adjusted EPS of $0.76-$0.78 in Q1, below estimates of $0.86. The guidance includes the impact of Venezuela's 33% devaluation, which the company says will hurt earnings by $0.05 in Q1. "Over the balance of 2013," Merck expects the effect to be $0.02. (PR)